Starting Tamiflu upon hospital admission can slash flu deaths by 40% compared with delaying treatment for two to five days, a new study from the Centers for Disease Control and Prevention (CDC) suggests.
Tamiflu (generic name oseltamivir) is one of four antiviral drugs that is currently FDA approved to treat the flu, or influenza. The drug targets two of the most common types of flu viruses — influenza A and B — and works by inhibiting a protein on the surface of the viruses that enables them to replicate within host cells.
